Medical costs for Korean patients with rheumatoid arthritis based on the national claims database

Rheumatology International

Volumn 32, Issue 9, 2012, Pages 2893-2899

  Kwon, Jeong Mi ^a   Cho, Soo Kyung ^b   Kim, Jin Hee ^b   Lee, Eui Kyung ^a  

^a Sookmyung Women's University   (South Korea)

^b Hanyang Institute of Bioscience and Biotechnology   (South Korea)

Author keywords

Biologics; Claims data; Medical costs; Rheumatoid arthritis (RA)

Indexed keywords

ANESTHETIC AGENT; DISEASE MODIFYING ANTIRHEUMATIC DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

ADULT; AGED; ANESTHESIA; ARTICLE; BILLING AND CLAIMS; COST OF ILLNESS; DATA BASE; DIAGNOSTIC TEST; DRUG COST; FEE; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HOSPITAL PATIENT; HUMAN; JOINT RADIOGRAPHY; JOINT SURGERY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAID; OUTPATIENT; PHYSIOTHERAPY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SOUTH KOREA; STEROID THERAPY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; DATABASES, FACTUAL; FEES, PHARMACEUTICAL; FEMALE; HEALTH CARE COSTS; HOSPITAL COSTS; HUMANS; INSURANCE CLAIM REVIEW; LENGTH OF STAY; MALE; MIDDLE AGED; REGRESSION ANALYSIS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84866352985     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-2117-2     Document Type: Article

References (15)

1. Cooper NJ (2000) Economic burden of rheumatoid arthritis: a systematic review. Rheumatol (Oxford) 39(1):28-33 (Pubitemid 30095403)
2. Kvien TK (2004) Epidemiology and burden of illness of rheumatoid arthritis. Pharmacoeconomics 22(2 Suppl 1):1-12 (Pubitemid 38269929)
3. Lundkvist J, Kastang F, Kobelt G (2008) The burden of rheumatoid arthritis and access to treatment: health burden and costs. Eur J Health Econ 8(Suppl 2):S49-S60
4. Lajas C, Abasolo L, Bellajdel B, Hernandez-Garcia C, Carmona L, Vargas E, Lazaro P, Jover JA (2003) Costs and predictors of costs in rheumatoid arthritis: a prevalence-based study. Arthritis Rheum 49(1):64-70 (Pubitemid 36286131)
5. Michaud K, Messer J, Choi HK, Wolfe F (2003) Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients. Arthritis Rheum 48(10):2750-2762 (Pubitemid 37280602)
6. Ruof J, Hulsemann JL, Mittendorf T, Handelmann S, von der Schulenburg JM, Zeidler H, Merkesdal S (2003) Costs of rheumatoid arthritis in Germany: a micro-costing approach based on healthcare payer's data sources. Ann Rheum Dis 62(6):544-549
7. Guillemin F, Durieux S, Daures JP, Lafuma A, Saraux A, Sibilia J, Bourgeois P, Sany J (2004) Costs of rheumatoid arthritis in France: a multicenter study of 1109 patients managed by hospitalbased rheumatologists. J Rheumatol 31(7):1297-1304 (Pubitemid 38879192)
8. Verstappen SM, Verkleij H, Bijlsma JW, Buskens E, Kruize AA, Heurkens AH, Van Der Veen MJ, Jacobs JW (2004) Determinants of direct costs in Dutch rheumatoid arthritis patients. Ann Rheum Dis 63(7):817-824 (Pubitemid 38850453)
9. Huscher D, Merkesdal S, Thiele K, Zeidler H, Schneider M, Zink A (2006) Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany. Ann Rheum Dis 65(9):1175-1183 (Pubitemid 44277392)
10. Jacobsson LT, Lindroth Y, Marsal L, Juran E, Bergstrom U, Kobelt G (2007) Rheumatoid arthritis: what does it cost and what factors are driving those costs? Results of a survey in a community-derived population in Malmo, Sweden. Scand J Rheumatol 36(3):179-183 (Pubitemid 47174541)
11. Kobelt G, WoronoV AS, Richard B, Peeters P, Sany J (2008) Disease status, costs and quality of life of patients with rheumatoid arthritis in France: the eco-pr study. Jt Bone Spine 75(4):408-415
12. Lubeck DP (2001) A review of the direct costs of rheumatoid arthritis: managed care versus fee-for-service settings. Pharmacoeconomics 19(8):811-818 (Pubitemid 32758545)
13. Rosery H, Bergemann R, Maxion-Bergemann S (2005) International variation in resource utilisation and treatment costs for rheumatoid arthritis: a systematic literature review. Pharmacoeconomics 23(3):243-257 (Pubitemid 40663631)
14. Kilian R, Matschinger H, LöeZer W, Roick C, Angermeyer MC (2002) A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment. J Ment Health Policy Econ 5(1):21-31 (Pubitemid 36054685)
15. Hulsemann JL, Ruof J, Zeidler H, Mittendorf T (2006) Costs in rheumatology: results and lessons learned from the 'Hannover costing study'. Rheumatol Int 26(8):704-711 (Pubitemid 43725463)